-
BioJet LLC Receives Pharmaceutical Manufacturing License
Read more: BioJet LLC Receives Pharmaceutical Manufacturing LicenseBioJet LLC has obtained a license from the Ministry of Industry and Trade of Russia granting it the right to manufacture medicinal products for medical use and/or drugs for clinical trials (testing). In addition, the company’s production facility has received a GMP certificate, confirming its compliance with the Good Manufacturing Practice standards of the Eurasian…
-
Roszdravnadzor plans to conduct around 120 pharmacovigilance inspections per year
Read more: Roszdravnadzor plans to conduct around 120 pharmacovigilance inspections per yearRoszdravnadzor plans to conduct around 120 pharmacovigilance inspections per year. The regulator will use a risk-based approach when drawing up the inspection plan. Checklists, as well as the cost of the inspection, have not yet been approved. Roszdravnadzor plans to conduct around 120 pharmacovigilance inspections per year. The plan will be drawn up based on…
-
Fewer failed public procurement auctions reported in the Russian pharmaceutical market
Read more: Fewer failed public procurement auctions reported in the Russian pharmaceutical marketWhile drug procurement tenders have increased and their total value has risen by 20%, competition is declining. The share of single-bidder procurements has reached 94%. Why are these auctions increasingly taking place without competition? The number of public procurement tenders is growing, but the lion’s share continues to involve only a single participant. An analysis…
-
Authorities raise growth forecast for Russian pharmaceutical production for 2026–2028
Read more: Authorities raise growth forecast for Russian pharmaceutical production for 2026–2028The Ministry of Economic Development of the Russian Federation (MED RF) has upgraded its growth forecast for the manufacturing of pharmaceuticals and medicinal materials for the 2026–2028 period. “In 2026, the production volume of the pharmaceutical industry is projected to increase by 12.1%. In the medium term, the sector is expected to transition from an…
-
China aims to increase global share of innovative drugs to 25%
Read more: China aims to increase global share of innovative drugs to 25%China has set a strategic goal to increase its share of domestically developed innovative drugs to at least 25% of the global total by 2030. This initiative specifically targets “first-in-class” (FIC) therapies featuring entirely novel mechanisms of action, as outlined in the Development Plan for the Pharmaceutical Industry of the People’s Republic of China (PRC)…
-
26 new pharmaceutical manufacturers enter Russian market since 2022
Read more: 26 new pharmaceutical manufacturers enter Russian market since 2022Since 2022, 26 new manufacturers have emerged in the Russian pharmaceutical market, bringing the total number of companies to 410. This was reported to TASS by Egor Zhavoronkov, Head of the Socially Significant Goods Management Directorate at the Center for Research in Perspective Technologies (CRPT, the operator of the “Chestny Znak” state track-and-trace marking system).…
-
Minpromtorg approves regulations for issuing drug production stage documents
Read more: Minpromtorg approves regulations for issuing drug production stage documentsThe Ministry of Industry and Trade of the Russian Federation (Minpromtorg) has approved the Administrative Regulations for providing the state service of issuing documents containing details on the technological stages of medicine manufacturing within the Eurasian Economic Union (EAEU). Decree No. 4746, signed on September 11, 2026, has been officially published on the state legal…
-
Pharmaceutical Manufacturers May Receive Priority State Support as “Technology Leaders”
Read more: Pharmaceutical Manufacturers May Receive Priority State Support as “Technology Leaders”Russia may introduce a new category of technology companies known as “technology leaders.” The Ministry of Economic Development has submitted a corresponding draft government resolution. Potential candidates for this status include drug developers, medical device manufacturers, and research organizations operating in the healthcare sector. A dedicated state register is expected to be created for these…
-
New Rules Approved for Remuneration for Employee Inventions
Read more: New Rules Approved for Remuneration for Employee InventionsThe Russian Government has approved new Rules for the Payment of Remuneration for Employee Inventions, Utility Models, and Industrial Designs. The document will take effect on September 1, 2026, remain in force for six years, and replace the corresponding 2020 regulations. Among other changes, the new rules introduce a method for calculating remuneration that takes…
-
Regulator Proposes Moving Confirmation of Pharmaceutical Localization to a Digital Register
Read more: Regulator Proposes Moving Confirmation of Pharmaceutical Localization to a Digital RegisterThe Russian Ministry of Industry and Trade has drafted a bill that could change the procedure for issuing documents confirming the stages of the technological process involved in manufacturing medicinal products within the Eurasian Economic Union (EAEU). Instead of issuing a paper or individual document, the proposal calls for the relevant information to be entered…